Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Endocrinol.

Sec. Thyroid Endocrinology

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1590294

Multimodal Ultrasonography in the Diagnosis and Treatment of Chronic Thyrotoxic Myopathy: A Prospective Study

Provisionally accepted
Roumei  WangRoumei Wang1Rui  HuangRui Huang1Shien  FuShien Fu1Yunxia  TangYunxia Tang2Yaoli  LiuYaoli Liu1*
  • 1First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi Zhuang Region, China
  • 2Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Region, China

The final, formatted version of the article will be published soon.

Objective: This study integrates high-frequency ultrasonography with shear wave elastography (SWE) to perform a multimodal quantitative assessment of the rectus femoris musculature and thyroid tissue architecture in patients with chronic thyrotoxic myopathy (CTM). ByA novel predictive model for CTM progression was developed by quantitatively assessing biomechanical parameters, including muscle fibrosis progression and thyroid parenchymal stiffness, a novel predictive model for CTM progression was developed, providing an objective imaging-based foundation for early disease intervention.Methods: This prospective study enrolled 75 patients with hyperthyroidism and 53 healthy controls. SWE was used for quantitatively assessing theThe biomechanical parameters of the rectus femoris muscle and thyroid tissue were quantitatively assessed using SWE. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive efficacy of rectus femoris and thyroid tissue elasticity parameters for CTM diagnosis. A multivariate logistic regression model was developed to investigate the association between muscle fibrosis severity, thyroid stiffness, and CTM risk. Additionally, patients with CTM received pharmacotherapeutic interventions, and clinical indexes were administered to patients with CTM,systematically monitored along with systematic monitoring of clinical indices and dynamic changes in thyroid and rectus femoris correlation parameters before and after treatment to evaluate the therapeutic efficacy.The CTM group exhibited a significantly lower mean Young's modulus (E-mean) of the rectus femoris than the non-CTM and healthy groups (p < 0.01), suggesting muscle fibrosis. ROC curve analysis revealed that the combined diagnostic approach achieved the highest sensitivity and specificity for CTM, with an area under the curve of 92.5%. A multivariate logistic regression model revealed that, after adjusting for confounding factors, both rectus femoris E-mean and thyroid E-mean were significant predictors of CTM. SignificantFollowing treatment with antihyperthyroid drugs, significant improvements were observed in thyroid hormone levels, upper and lower limb muscle function tests, and muscle-related parameters compared with their pretreatment levels following treatment with antihyperthyroid drugs, with all differences reaching statistical significance (p < 0.01).By quantitatively assessing the morphological and biomechanical characteristics of the rectus femoris and thyroid gland, multimodal ultrasonography can provide a reliable imaging basis for the early prediction and therapeutic monitoring of CTM.

Keywords: Chronic Thyrotoxic Myopathy, Shear wave elastography, Rectus femoris, Thyroid Gland, Ultrasonography

Received: 09 Mar 2025; Accepted: 18 Aug 2025.

Copyright: © 2025 Wang, Huang, Fu, Tang and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yaoli Liu, First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Region, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.